The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



PIPE - II | Dead

Total Raised


Last Raised


About Benten BioServices

Benten BioServices (fka Deltagen Bioservices) provides high quality, regulatory-compliant services supporting the development and commercialization of biopharmaceutical products. Services include adventitious agent detection for virus, bacteria, mycoplasma, fungi, etc.; vaccine and cellular therapy Phase I & II clinical lot manufacturing; and cell banking and characterization.

Benten BioServices Headquarter Location

347 Phoenixville Pike

Malvern, Pennsylvania, 19355,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Benten BioServices News

Bioservices Market 2021 by Global Industry Revenue, Current Trend, Size, Share, Competition, Growth, Price, Profit, Capacity and Future Forecast till 2021 to 2027| Quintiles, BeijingWits, Specialty Ranbaxy, Benten BioServices, Novartis

Feb 15, 2021

| Quintiles, BeijingWits, Specialty Ranbaxy, Benten BioServices, Novartis The latest report titled Global Bioservices Market Size, Share, Growth, Industry Trends and Forecast to 2028 provides various levels of analysis such as industry analysis (industry trends), market size, growth, revenue, share analysis of top players, emerging and high-growth segments of the market, and high-growth regions. The report includes valuable insights based on market valuation, market size, revenue forecast for 2020 to 2028 time-period. The report provides an overall view of the market drivers, restraints, challenges, and opportunities. The study presents a precise summary of the global Bioservices market and competitive spectrum while drawing attention to the growth prospects and expansion plans adopted by key market players. Download Free Sample (350 Pages PDF, Full TOC, List of Tables & Figures, and Chart) Report@ DBMR analyses the Global Bioservices Market growing at a CAGR of 6.70% in the forecast period. The accelerating ratio of over 600 cases which are very recent in the sectors of medicines, pharmaceuticals laboratories, and biotech research and engineering, medical tools and devices will drive the bioservices market globally in the anticipated time period. Bioservices Market Overview: Surging volume of suffering patients who require the urgent need of advanced medical services and the government initiatives to provide the monetary support and capital inputs to clinical research centres are capturing the seeds of potential development in the bioservices industry and market. In the ascending years the market outlook and analyst insights foresees a major growth to be attributed by major biotech and pharmaceutical enterprises. Owing to these factors bioservices market is tending to move upward the success vertical in the prophesised year of 2020 to 2027. Minimal cost input and low labour costing is the foremost reason for the expansion of bioservices market. The lacking requirement of high skilled and efficient staff will curb down the market growth while the high-cost input and slow rate of solid development will hamper the market germination in the forecasted period of time. Bioservices is defined as aids and services rendered to add in the improvement of support and research to clinical trials, healthcare sectors, biotech industries, educational startegies so that these all can channelize and strengthen their progress of research is known as bio-services. The bioservices market comprises of experimenting with distinct cell-based tools and equipment, phase of development, clinical examination, and scientific research and analysis to help the biotechnology industry. Global Bioservices Market 2021 Report encompasses an infinite knowledge and information on what the market’s definition, classifications, applications, and engagements are and also explains the drivers and restraints of the market which is obtained from SWOT analysis. By applying market intelligence for this Bioservices Market report, industry expert measure strategic options, summarize successful action plans and support companies with critical bottom-line decisions. Additionally, the data, facts and figures collected to generate this market report are obtained forms the trustworthy sources such as websites, journals, mergers, newspapers and other authentic sources. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, price, cost, revenue and gross margins. According to this report Global Bioservices Market will rise from Covid-19 crisis at moderate growth rate during 2020 to 2028. Bioservices Market includes comprehensive information derived from depth study on Bioservices Industry historical and forecast market data. Global Bioservices Market Size To Expand moderately as the new developments in Bioservices and Impact of COVID19 over the forecast period 2020 to 2028. To Understand How Covid-19 Impact Is Covered In This Report, Get Free Covid-19 Sample @ Bioservices Market report provides depth analysis of the market impact and new opportunities created by the COVID19/CORONA Virus pandemic. Report covers Bioservices Market report is helpful for strategists, marketers and senior management, And Key Players in Bioservices Industry. Global Bioservices Industry Key Segmentation By Industry (Clinical Research Organizations (CROs), Contract Manufacturers Organizations(CMOs), and Contract Research and Manufacturing Services (CRAMS) By Research (Pharmaceutical, Biotechnological, Academic, Clinical Trial And Healthcare Sectors) By Application Areas (Donor Recruitment, Tissue Collection, Cell Processing and Isolation, Research & Development) List of Companies Profiled in the Bioservices Market Report are: Bio Services LLC …. Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart) @ Bioservices Report displays data on key players, major collaborations, merger & acquisitions along with trending innovation and business policies. The report highlights current and future market trends and carries out analysis of the effect of buyers, substitutes, new entrants, competitors, and suppliers on the market. The key topics that have been explained in this Bioservices market report include market definition, market segmentation, key developments, competitive analysis and research methodology. To accomplish maximum return on investment (ROI), it’s very essential to be acquainted with market parameters such as brand awareness, market landscape, possible future issues, industry trends and customer behavior where this Bioservices report comes into play. Bioservices Market Scope and Market Size The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insight to help them in making strategic decisions for identification of core market applications. On the basis of industry, bioservices market is segmented into clinical research organizations (CROs), contract manufacturer’s organizations, and contract research and manufacturing services (CRAMS) On the basis of research bioservices market has also been fragmented into pharmaceutical, biotechnological, academic, clinical trial and healthcare sectors. Further bioservices market is bifurcated on the basis of application areas, which are as follows donor recruitment, tissue collection, cell processing and isolation, research & development. For More Information or Query or Customization Before Buying, Visit @ Key Benefits of the Report:                                                            * Global, regional, country, product purity, application, and grade market size and their forecast from 2020-2028 * Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market * Detailed analysis on industry outlook with market specific Porter’s Five Forces analysis, PESTLE analysis, and Value Chain, to better understand the market and build expansion strategies * Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points * Analysis on Key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, sales contracts, and new product launches in the market * Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies * Detailed insights on emerging regions, product purity, application, and grade with qualitative and quantitative information and fact * Identification of the key patents filed in the Bioservices Access a Complete Research Report Enabled with COVID-19 Impact Coverage @ Major Key Contents Covered in Bioservices Market: Introduction of Bioservices with development and status. Manufacturing Technology of Bioservices with analysis and trends. Analysis of Global Bioservices market Key Manufacturers with Company Profile, Product Information, Production Information, and Contact Information. Analysis of Global Bioservices market Capacity, Production, Production Value, Cost and Profit Analysis Bioservices Market with Comparison, Supply, Consumption, and Import and Export. Bioservices market Analysis with Market Status and Market Competition by Companies and Countries. 2020-2028 Market Forecast of Global Bioservices Market with Cost, Profit, Market Shares, Supply, Demands, Import and Export Trending factors influencing the market shares of APAC, Europe, North America, and ROW? Bioservices Market Analysis of Industry Chain Structure, Upstream Raw Materials, Downstream Industry Strategic Points Covered in Table of Content of Global Bioservices Market:         Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Bioservices market Chapter 2: Exclusive Summary – the basic information of the Bioservices Market. Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Bioservices Chapter 4: Presenting the Bioservices Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis. Chapter 5: Displaying market size by Type, End User and Region 2010-2019 Chapter 6: Evaluating the leading manufacturers of the Bioservices market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2020-2028). Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Finally, Bioservices Market is a valuable source of guidance for individuals and companies in decision framework. Browse Full Summary of Bioservices Market Enabled with Respective Tables and Figures at: Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. OUR OTHER REPORTS:- About Data Bridge Market Research, Private Ltd Data Bridge Market Research  Pvt  Ltd  is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market. Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve. Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include

  • When was Benten BioServices founded?

    Benten BioServices was founded in 1997.

  • Where is Benten BioServices's headquarters?

    Benten BioServices's headquarters is located at 347 Phoenixville Pike, Malvern.

  • What is Benten BioServices's latest funding round?

    Benten BioServices's latest funding round is PIPE - II.

  • How much did Benten BioServices raise?

    Benten BioServices raised a total of $37.05M.

  • Who are the investors of Benten BioServices?

    Investors of Benten BioServices include aPriori Capital Partners, Sprout Group, Boston Millennia Partners, Baccharis Capital, Cooper Hill Partners and 11 more.

  • Who are Benten BioServices's competitors?

    Competitors of Benten BioServices include Ra Pharmaceuticals, Milestone Pharmaceuticals, Receptos, Karmic Lifesciences, Plexigen and 11 more.

You May Also Like

Solidus Biosciences Logo
Solidus Biosciences

Solidus Biosciences is a company that received a STTR Phase II grant for a project entitled: Development of a Lead Optimization Chip for Drug Discovery. Their award is funded under the American Recovery and Reinvestment Act of 2009 and their project will address further development and commercialization of a multi-enzyme lead optimization chip (Multizyme Chip) for high-throughput generation of lead compound analogs coupled with cell-based screening for the rapid identification of biologically active derivatives. Such a capability directly impacts a key bottleneck in drug discovery; namely, the efficient optimization of lead compounds to develop drugs with optimal pharmacological properties. Solidus Biosciences, Inc. proposes to combine six biocatalysis with pharmacological screening to provide rapid identification of biologically active compounds against cell-specific targets, which is a new paradigm for lead optimization. Moreover, the Multizyme Chip platform will be well-suited for lead optimization in related industries, including agrochemicals, cosmetics, and cosmeceuticals. The Solidus technology will thus improve the competitiveness and efficiency of the pharmaceutical, cosmetics, and chemical industries, and will serve as a rich source of new and improved commercial products. The broader impacts of this research are the advances that Solidus Biosciences will achieve toward generating better and safer drugs, reducing the cost to develop these drugs, and increasing the overall efficiency of the pharmaceutical industry. Solidus will generate Multizyme Chips for purchase by pharmaceutical and biotechnology companies to facilitate their lead optimization programs, particularly those involving natural product-derived and complex synthetic small molecule leads. Cryopreservation techniques developed in Phase II will enable the sale of chips and chip-handling devices produced during Phase I, and will allow seamless penetration of the Solidus technology platform into the company's target markets. Solidus Biosciences is a company that received a STTR Phase I grant for a project entitled: Development of a Lead Optimization Chip for Drug Discovery. Their research project aims to develop a new method for generating lead compounds by using enzymatic modification of compound sets. Availability of new methodology to generate biologically active compounds from existing molecules may enhance the success of the drug discovery process and may lead to the discovery of new and useful therapeutics. Solidus Biosciences is a company that received a STTR Phase I grant for a project entitled: High-Throughput RNAi Screening of Mammalian Cells. Their research project aims to develop a system for the rapid screening of siRNAs that can inhibit genes involved in cellular responses such as hyperosmotic stress that can affect pathways of high commercial importance, including protein production. Use of hyperosmotic stress as a proof of concept system will demonstrate the feasibility of high-throughput RNAi screening and will at the same time yield results that can be used to improve monoclonal antibody production in commercial and laboratory settings Production of biopharmaceuticals such as antibodies is exquisitely responsive to the culture conditions under which the cells are grown and thus can be improved through optimizing such settings, which in turn, would affect the genes involved in the specific synthetic pathways of interest. Development of a rapid methodology to identify inhibitory RNA molecules that can inhibit genes that adversely affect yield would be of significant importance to pharmaceutical companies that produce protein therapeutics and may result in a lowering of the const of these therapeutic entities.


QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. Focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities.

Presage Biosciences Logo
Presage Biosciences

Presage Biosciences is an oncology company that focuses on evaluating patient response to drugs in clinical trials. The company uses CIVO technology to deliver pharmacologically appropriate concentrations of multiple drugs to different regions of a tumor – while the tumor is still in the patient.


NeuroGenomeX is a drug discovery company developing novel treatments for diseases of the brain and nervous system. The current NeuroGenomeX discovery program is focused on therapeutic target areas of epilepsy and traumatic brain injury. NeuroGenomeX is advancing its lead drug candidate, 2-deoxy-D-glucose (2DG), as an anticonvulsant that stops seizures and has beneficial effects against adverse long-term consequences of epilepsy. 2DG also has shown favorable therapeutic neuroprotective effects in animal models of traumatic brain injury (TBI).


Allozyne is a protein optimization company committed to the development of improved biological therapeutics to treat multiple areas of unmet medical need. Allozyne's two technology platforms enable the incorporation of amino acids analogues, at any specified position, into existing biologics leading to improved efficacy, tolerability and pharmacology.

Shamrock Structures Logo
Shamrock Structures

Shamrock Structures is a structural proteomics company focused on assisting pharmaceutical and biotechnology clients reduce the time it takes to advance from protein targets to drugs by offering integrated services in structural proteomics including protein cloning, expression, purification and crystallization.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.